GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (FRA:MFY) » Definitions » Shiller PE Ratio

Mochida Pharmaceutical Co (FRA:MFY) Shiller PE Ratio : 13.19 (As of May. 17, 2024)


View and export this data going back to . Start your Free Trial

What is Mochida Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-17), Mochida Pharmaceutical Co's current share price is €17.80. Mochida Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was €1.35. Mochida Pharmaceutical Co's Shiller PE Ratio for today is 13.19.

The historical rank and industry rank for Mochida Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

FRA:MFY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.9   Med: 16.96   Max: 27.34
Current: 14.27

During the past years, Mochida Pharmaceutical Co's highest Shiller PE Ratio was 27.34. The lowest was 13.90. And the median was 16.96.

FRA:MFY's Shiller PE Ratio is ranked better than
77.3% of 533 companies
in the Drug Manufacturers industry
Industry Median: 25.16 vs FRA:MFY: 14.27

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.287. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €1.35 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mochida Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Mochida Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co Shiller PE Ratio Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.54 20.24 17.02 15.18 -

Mochida Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.18 14.88 15.18 15.28 -

Competitive Comparison of Mochida Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's Shiller PE Ratio falls into.



Mochida Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mochida Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=17.80/1.35
=13.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.287/106.8000*106.8000
=0.287

Current CPI (Dec. 2023) = 106.8000.

Mochida Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.244 95.700 0.272
201406 0.345 98.000 0.376
201409 0.212 98.500 0.230
201412 0.578 97.900 0.631
201503 0.203 97.900 0.221
201506 0.580 98.400 0.630
201509 0.302 98.500 0.327
201512 0.681 98.100 0.741
201603 -0.050 97.900 -0.055
201606 0.697 98.100 0.759
201609 0.504 98.000 0.549
201612 0.871 98.400 0.945
201703 -0.265 98.100 -0.289
201706 0.873 98.500 0.947
201709 0.306 98.800 0.331
201712 0.631 99.400 0.678
201803 -0.048 99.200 -0.052
201806 1.145 99.200 1.233
201809 0.210 99.900 0.225
201812 0.575 99.700 0.616
201903 -0.287 99.700 -0.307
201906 0.690 99.800 0.738
201909 0.277 100.100 0.296
201912 0.377 100.500 0.401
202003 -0.386 100.300 -0.411
202006 0.717 99.900 0.767
202009 0.424 99.900 0.453
202012 0.614 99.300 0.660
202103 0.036 99.900 0.038
202106 0.523 99.500 0.561
202109 0.456 100.100 0.487
202112 1.071 100.100 1.143
202203 0.079 101.100 0.083
202206 0.593 101.800 0.622
202209 0.145 103.100 0.150
202212 0.783 104.100 0.803
202303 -0.274 104.400 -0.280
202306 0.302 105.200 0.307
202309 0.204 106.200 0.205
202312 0.287 106.800 0.287

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mochida Pharmaceutical Co  (FRA:MFY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mochida Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mochida Pharmaceutical Co (FRA:MFY) Business Description

Traded in Other Exchanges
Address
1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (FRA:MFY) Headlines

No Headlines